Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Leukemia & Lymphoma|November 12, 2020
Life-threatening complications after high-dose methotrexate and the benefits of glucarpidase as salvage therapy: a cohort study of 468 patientsChloé Medrano, Lucie Oberic, Florent Puisset, et al.
European Journal of Clinical Pharmacology|January 15, 2020
Association between clinically relevant toxicities of pazopanib and sunitinib and the use of weak CYP3A4 and P-gp inhibitorsCamille Azam, Pauline Claraz, Christine Chevreau, et al.
British Journal of Clinical Pharmacology|March 1, 2023
Investigating the clinical impact of dose-banding for weekly paclitaxel in patients with breast cancer: A retrospective and monocentric studyFlorent Puisset, Félicien Le Louedec, Florence Dalenc, et al.
Clinical Pharmacokinetics|March 9, 2026
Model-Informed Precision Dosing of Protein Kinase Inhibitors: Evaluation of Model-Averaging and Flattened Priors MethodsFélicien Le Louedec, Laura Morvan, Loïc Mourey, et al.
International Immunopharmacology|June 5, 2023
Infectious risk when prescribing rituximab in patients with hypogammaglobulinemia acquired in the setting of autoimmune diseasesXavier Boumaza, Margaux Lafaurie, Emmanuel Treiner, et al.
Annales Pharmaceutiques Francaises|July 12, 2025
Oncology pharmacy practice: Key insights, challenges, and perspectives - A position paper from the French Society for Oncology Pharmacy (SFPO)Florence Ranchon, Florian Slimano, Isabelle Borget, et al.
Haematologica|October 17, 2024
Exposure toxicity of venetoclax in acute myeloid leukemia patients in the real-life setting: impact of high exposure on delayed neutropeniaFlorent Puisset, Emmanuel Raffoux, Lionel Ades, et al.
British Journal of Cancer|January 25, 2024
Exposure-response relationship of cabozantinib in patients with metastatic renal cell carcinoma treated in routine careBenoit Blanchet, Alexandre Xu-Vuilard, Anne Jouinot, et al.
Nature Communications|January 25, 2020
Resistance of melanoma to immune checkpoint inhibitors is overcome by targeting the sphingosine kinase-1Caroline Imbert, Anne Montfort, Marine Fraisse, et al.
Cancer Medicine|December 9, 2022
Retrospective, real-life study of venetoclax plus azacitidine or low-dose cytarabine in French patients with acute myeloid leukemia ineligible for intensive chemotherapyLouise Laloi, Natacha Chaumard Billotey, Pierre-Yves Dumas, et al.
Pageof 3